CRISPR reveals possible ALS drug target – FierceBiotech
FierceBiotechCRISPR reveals possible ALS drug targetFierceBiotechAmyotrophic lateral sclerosis (ALS) is driven by protein “aggregates,” or clumps in the brain, that make voluntary muscle movements progressively more difficult. Problem is, scientists ha… Continue reading
